Impact of Bad Communication on the Patient

collision of Bad Communication on the PatientPatients outcomes and the jolt of appropriate hearing carried out by an esthetic nurse.Introduction estheticals is one of the fastest growing specialties of medical lend oneself. Aesthetic nurses play a signifi substructuret fiber in delivering aesthetic non-surgical discussions. They administer around 70 per cent of all non-surgical treatment. They typically work in a snip of authoritys within the NHS and the private sector. Aesthetic nurses practise in clinical scartings. Their portions bridge deck a broad range of t implore including systematic problem resoluteness and the eliminatement of persevering requirements. Aesthetic nurses play a make role in longanimous caveat nerve pathway and are responsible for the purvey of the sound in contour lineation about treatment and products, making diagnoses, creating a care plan and ensuring that patients receive the best treatment. Aesthetic nurses are alike responsible fo r evaluation of patients treatment outcomes and progress towards achieving rise-being and health (Fry et al., 2011).The focusing of health problems poses several challenges including having the right skills, attitude, expertise and knowledge to manage patients postulate. Aesthetic nurses need to possess the right knowledge, communicatory and ethical skills to minimise the risk of clinical errors. These aspects are all-important(a) to delivering impressive and positive outcomes during the management of patients needs.The general patient pathway comprises of an assessment that is carried out by the nurse during a consultation. This step is key to the management of patient risk, health and wefts. Ineffective assessment and consultation could get out in the ill- successiond treatment prescription with the potential emotional, physical and mental harm of the patients health.In this model study, I lead apply Gibbs reflective model (Jasper, 2003) to describe and present how escape of communication and incorrect treatment could lead to patients incommode caused by the maturement of unfortunate effect follow up oning an aesthetic treatment. effort description using Gibbs approachA 35-year-old woman came in to the clinic complaining of painful, irritated strip on both the right and left(a) side of her face and the forehead. In particular, she reported signs of inflammation around the nasal-labial crimp and perioral domain of a function, and in the buccal and frontal area. She noticed the problem within a day aft(prenominal) receiving an aesthetic treatment at the clinic. She underwent a flux of dermal makeweight injections containing Restylene to reduce the signs of lines and wrinkles in the frontal, buccal and nasal-labial areas. Although she was warned, she may get under ones skin some soreness and redness the patient was not aware of the type of active substances in her dermal fillers. She also has not been given a range of options of tr eatment and she did not receive any leaflets about the after care. She was presented with red, swollen and painful skin in particular during smiling or speaking. The patient came in to the clinic three eld after her treatment and she was assessed by her aesthetic nurse. The nurse examined her face and prescribed her 1% hydrocortisone ointment with the application of three time a day to the patients face for the duration of 7 days. Unfortunately, her symptoms waneed within three days of this treatment and the unhappy and di tenored patient went to see a doctor. aft(prenominal) careful examination and consultation with the doctor, the patient was diagnosed with a skin transmission caused by the treatment she had at the aesthetic clinic. The patients skin presented with even greater inflammation characterised by pustules and yellow crusts in the area where the dermal filler injections took place. The doctor prescribed the patient a get over of antibiotics taken externally as a s cramble in the salmagundi of Bactroban three times daily and Clarithromycin 200 mg 4 times a day. The course of antibiotic treatment lasted 7 days resulting in positive outcomes for the patient. During the patients visit to the doctor, I took part in the consultation, examination and medical history assessment. I reflected on my practice act to identify the signs and symptoms that I missed to correctly diagnose this patient. I established that perhaps I did not understand fully what the patient was effect and therefore, misdiagnosed the risk of her signs and symptoms. I realised that effective risk assessment is crucial to correct diagnosing and treatment prescription as healthful as management of quality patient care. What is more, I did not give the patient enough averation about the after care and did not ask to pay attention to likely signs of possible contrary effects.EvaluationThe case study described above shows an example of negligence in clinical aesthetic practice . It underlies common mistakes health care practitioners make when consulting and prescribing products and treatments. To avoid controvert practice it is crucial to identify the cause of the problem, how the symptoms developed and what steps earth-closet be taken to avoid the problem.Reflective practice and the right consultation between patients and health care professionals are valuable tools for effective treatment management and provision of high quality care (PMETB, 2008). It is evident that in the case study described above the aesthetic nurse failed to set forth the patient about the choice of products and their possible side effects. Todays patients need to be fully informed about the chemical account of the products and their effects on their physical health. This is very important especially that immediatelys health care aims to address patients physical, emotional, psychological and tumesce-being needs. As the patient was not presented with options followed by infor med instructions, the patient was not able to make the right decision concerning which products she should have chosen. Whilst dermal fillers are not legally regulated and are accepted as harmless (MHRA, 2009), evidence suggests they may lead to health complications (Funt and Pavicic, 2013). For example, intra-arterial dermal filler injection with hyaluronic acid might lead to extensive injury of the thread and necrosis (Delorenzi, 2014). Other products such as Juvederm Ultra may also lead to local inflammation, formation of nodules, tissue damage, and necrosis and other unfortunate reactions (Allergan, 2010). Common clinical symptoms following hyaluronic acid injections include skin blanching, slow refilling of the capillaries, discolouration of the skin, livedo reticularis that might be followed by more unbecoming symptoms such as formation of blisters and tissues damage (Delorenzi, 2014). Prompt recognition of these signs and symptoms by the aesthetic nurse are the mainstays of effective treatment. The effective treatment at an early stage would involve prescription of hyaluronidase, brass of anti-inflammatories such as oral acetylsalicyclic acid (aspirin) and local occlusion with nitropaste. Warm compresses and vigorous abrade to affected area can also help to minimise stress (Delorezni, 2014). Meticulous proficiency during the dermal filler injection could prevent the above adverse effects. Therefore, patients should be informed about the types of products and their respective composition and possible adverse reactions. Aesthetic nurse plays a key role in the provision of this information and after care. In particular, patients can be enthrone by receiving the right information about the after care and should be alarmed to keep an eye on any possible adverse effects (Cohen, 2008). Early identification of any adverse effects for the most part results in lower negative health impacts. All nurses should follow the guidelines set out by the Nursing a nd Midwifery Council as described in Standards for medicine management (NMC, 2011). This highlights that communication between the nurse and the patient is extremely important in minimising risk following aesthetic treatments as well as provision of high quality patient care and straight practice.AnalysisThis case study highlights an example of aesthetic nurse negligence, where firstly, she failed to inform the patient about the possible consequences of the products and treatment she had, secondly, she did not provide the right after care and thirdly, failed to diagnose her symptoms correctly after the treatment. She misdiagnosed patients symptoms as an inflammatory reaction rather than infection and therefore, prescribed the wrong treatment of 1% hydrocortisone cream to treat the symptoms. The nurse failed to throw out a correct assessment and examination and failed to address the health symptoms adequately according to the guidelines developed by National Prescribing Centre (Co urtney and Griffiths, 2010). The guidelines follow principles of good practice recommending considerations for the patient including a thorough medical examination, choice of appropriate treatment, and prescription of correct drugs for the respective symptoms. 1 % hydrocortisone cream was inadequately prescribed because it is not the right treatment to alleviate symptoms of infection. What is more, its immunosuppressing properties could worsen the symptoms and increase the predisposition to infection (JFC, 2011). The right treatment should have been prescription of antibiotics according to the guidelines for the treatment of skin infections set out by the British Association of Dermatologists (BAD, 2008). The treatment of a topical cream in the form of Bactroban three times daily and Clarithromycin 200 mg 4 times a day was confirmed by the doctor at a later stage and resulted in improved outcomes for the patients symptoms. If the symptoms were identify and diagnoses at an earlier st age, the patient could have been just treated with the topical form of antibiotics. However, due to the advanced form of inflammation oral administration of antibiotics was also prescribed. potent consultation and accurate diagnosis by the aesthetic nurse could have prevented unnecessary distress to the patient. A meticulous technique used by the aesthetic clinician during dermal filler injections could have prevented development of the adverse effects all together.Conclusion and action planThe quick growing range of non-surgical treatments and products including dermal fillers for the use in aesthetic woolly tissue augmentation has benefits to both patients and physicians, but as indicated in this case study, as the number of products grows, the number of complications is also likely to expand. There are a number of steps that can be taken to avoid errors in aesthetic breast feeding practice. Communication at the right time with the patient as well as written advice may help emp ower patinets choices over the types of products and treatments that are most suitable to them. Today, patients have nark to information through the means of internet and expect to be well informed about all possible complications associated with the use of aesthetic products. It is the role of the nurse to make sure patients have the right information at the right time. The information about the side effects and adverse reactions of the aesthetic products is available on many of the pharmaceutical companies websites. Companies such as Allergan, Merz and Galderma normally provide detailed protocols and guidelines to practitioners about their products. They even provide templates for taking demographic and medical history notes, treatment guidelines, and flyers containing all the information patient needs to know about pre and post-care and possible adverse reactions. It is recommended that aesthetic centres develop their accept standards of care so that their patients can be infor med well. The above strategies can be easily deployed to minimise the incidence and impact of complications associated with dermal filler injections. Knowledge about the products and potential adverse effects and their risk management will enhance the use of the products and influence good aesthetic nursing practice. For optimum outcomes, aesthetic clinical practitioners should have good knowledge of the general anatomy of facial structures the prospective characteristics of the wide range of dermal fillers their implications, contraindications, beneficial effects and setbacks and strategies to prevent and avoid possible complications.Continuing professional development is a good way to keep up-to-date with the latest scientific findings and allows designation with other professionals in the field to develop optimum treatment options and management. low practice should always be reported to ensure best outcomes for the patients in the future (NMC, 2011).Overall, quality care that patients receive depends on accurate diagnosis and prescription of drugs and treatment that involves communication skills, compassion, and care from healthcare professionals as well as knowledge, experience and expertise that is necessary to make correct diagnoses. Effective management of patient clinical risk and learning from reflective practice leads to the provision of high quality care to patients at the right time in the right place and satisfied patients.ReferencesAllergan (2010). Juvederm Ultra 4. Summary of produce Characteristics. Pringy Allergan.Cohen, J., L., (2008) Understanding, avoiding, and managing dermal filler complications. Dermatol Surg. 34 Suppl 1S92-9. .Courtney, M., Griffiths, M., (2010) Independent and supplementary prescribing. An infixed Guide. 2nd Ed. Cambrdige. Cambridge University Press.Delorenzi, C., (2014) Complications of injectable fillers, part 2 vascular complications. Aesthet Surg J. 4(4)584-600.Fry, S., T., Veatch, R., M., Taylor, C., R., (20 11) Case Studies in Nursing Ethics, Jones and Bartlett Learning, 4th Ed.Funt, D., Pavicic, T., (2013) Dermal fillers in aesthetics an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 126295-316.Jasper, M., (2003). Beginning Reflective Practice. Cheltenham. Nelson Thornes.Joint pharmacopeia Committee (2011). British National Formulary 61. London. British medical checkup ledger Group and Pharmaceutical Press.Medicines and Healthcare product regulatory agency (MHPRA) (2009). Borderlines with medical exam Devices. London. MHRA.Nursing and Midwifery Council (2011) Remote prescribing and injectable cosmetic medicinal products. London, NMC.grad student Medical Education and Training Board (PMETB), (2008), Patients role in healthcare. The future relationship between patient and doctor. General Medical Council.